StrainRx Appoints New Head of Clinical Research
LOS ANGELES, April 17, 2019 (Newswire.com) - StrainRx is a cannabis intelligence platform that facilitates the identification and location of cannabis products that are ideally suited for users' complex and nuanced needs. To further the platform's expertise and understanding of the cannabis plant and its pharmacological potential, StrainRx is announcing the appointment of Justin Tran to the executive team as the head of clinical research.
We are positioned between the world of sourcing (the cultivators), and the world of academia, and as such, StrainRx has an opportunity to become a major player in guiding the future of cannabis R&D.
Alec Perelman, CEO
Source: StrainRx
Share:
Tags: cannabis, cannabis education, cannabis research, health and wellness, Justin Tran, medical marijuana, StrainRx